{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:20:09Z","timestamp":1787761209343,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejphar.2024.176675","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T11:14:21Z","timestamp":1717154061000},"page":"176675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ibrutinib, a Bruton's tyrosine kinase inhibitor, regulates ventricular electromechanical activities and enhances arrhythmogenesis"],"prefix":"10.1016","volume":"977","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7235-273X","authenticated-orcid":false,"given":"Chih-Min","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong-Jhih","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chheng","family":"Chhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Kuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Yu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Shun","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5735-6249","authenticated-orcid":false,"given":"Satoshi","family":"Higa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ann","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7224-4491","authenticated-orcid":false,"given":"Yi-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176675_bib1","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jemermed.2016.10.019","article-title":"A perfect storm: tyrosine kinase inhibitor-associated polymorphic ventricular tachycardia","volume":"52","author":"Beyer","year":"2017","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.ejphar.2024.176675_bib2","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1056\/NEJMoa1509388","article-title":"Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia","volume":"373","author":"Burger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2024.176675_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7040062","article-title":"Novel indications for Bruton's tyrosine kinase inhibitors, beyond hematological malignancies","volume":"7","author":"Campbell","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejphar.2024.176675_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/j.1540-8167.2011.02126.x","article-title":"Heart failure enhanced pulmonary vein arrhythmogenesis and dysregulated sodium and calcium homeostasis with increased calcium sparks","volume":"22","author":"Chang","year":"2011","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib5","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1158\/1535-7163.MCT-15-0923","article-title":"Ibrutinib inhibits ERBB receptor tyrosine kinases and HER2-amplified breast cancer cell growth","volume":"15","author":"Chen","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.ejphar.2024.176675_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/01.CIR.101.13.1606","article-title":"Alteration of ventricular fibrillation by flecainide, verapamil, and sotalol: an experimental study","volume":"101","author":"Chorro","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.176675_bib7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00280-017-3471-x","article-title":"Ibrutinib does not prolong the corrected QT interval in healthy subjects: results from a thorough QT study","volume":"80","author":"de Jong","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176675_bib8","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.2147\/DDDT.S377697","article-title":"Ibrutinib-associated cardiotoxicity: from the pharmaceutical to the clinical","volume":"16","author":"Dong","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejphar.2024.176675_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.749022","article-title":"Effects of the Btk-inhibitors remibrutinib (LOU064) and rilzabrutinib (PRN1008) with varying Btk Selectivity over Tec on platelet aggregation and in vitro bleeding time","volume":"8","author":"Duan","year":"2021","journal-title":"Front Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2024.176675_bib10","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2013-06-507947","article-title":"Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes","volume":"122","author":"Dubovsky","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2024.176675_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176675_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.630942","article-title":"Comparative analysis of BTK inhibitors and mechanisms underlying adverse effects","volume":"9","author":"Estupi\u00f1\u00e1n","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2024.176675_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1073274820931808","article-title":"Electrocardiographic changes associated with ibrutinib exposure","volume":"27","author":"Fradley","year":"2020","journal-title":"Cancer Control"},{"key":"10.1016\/j.ejphar.2024.176675_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.hrthm.2016.10.015","article-title":"A type 2 ryanodine receptor variant associated with reduced Ca(2+) release and short-coupled torsades de pointes ventricular arrhythmia","volume":"14","author":"Fujii","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejphar.2024.176675_bib15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jacep.2018.06.004","article-title":"Ibrutinib-associated atrial fibrillation","volume":"4","author":"Ganatra","year":"2018","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib16","article-title":"Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo's cardiomyopathy","volume":"1","author":"Giza","year":"2017","journal-title":"Eur. Heart J. Case Rep."},{"key":"10.1016\/j.ejphar.2024.176675_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-8597-5_7","article-title":"Measuring cardiomyocyte contractility and calcium handling in vitro","volume":"1816","author":"Gorski","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2024.176675_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCEP.111.000152","article-title":"Apamin-sensitive potassium current modulates action potential duration restitution and arrhythmogenesis of failing rabbit ventricles","volume":"6","author":"Hsieh","year":"2013","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib19","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1111\/jcmm.17052","article-title":"Calcium dysregulation increases right ventricular outflow tract arrhythmogenesis in rabbit model of chronic kidney disease","volume":"25","author":"Huang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176675_bib20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1161\/01.RES.87.12.1095","article-title":"Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C","volume":"87","author":"Kamp","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176675_bib21","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1182\/blood-2016-10-742437","article-title":"Ventricular arrhythmias and sudden death in patients taking ibrutinib","volume":"129","author":"Lampson","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2024.176675_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175493","article-title":"Modulation of post-pacing action potential duration and contractile responses on ventricular arrhythmogenesis in chloroquine-induced long QT syndrome","volume":"941","author":"Liu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176675_bib23","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00424-020-02445-7","article-title":"Concurrent increases in post-pacing action potential duration and contractility predict occurrence of ventricular arrhythmia","volume":"472","author":"Liu","year":"2020","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ejphar.2024.176675_bib24","article-title":"Adenosine monophosphate-regulated protein kinase inhibition modulates electrophysiological characteristics and calcium homeostasis of rabbit right ventricular outflow tract","author":"Lu","year":"2023","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.176675_bib25","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/jcmm.12329","article-title":"Distinctive electrophysiological characteristics of right ventricular out-flow tract cardiomyocytes","volume":"18","author":"Lu","year":"2014","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176675_bib26","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0735-1097(00)00962-1","article-title":"Measurement, interpretation and clinical potential of QT dispersion","volume":"36","author":"Malik","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib27","first-page":"1631","article-title":"Why is the right ventricular outflow tract so arrhythmogenic? (... or is it really?","volume":"97","author":"Maury","year":"2011","journal-title":"Heart (British Cardiac Soc.)"},{"key":"10.1016\/j.ejphar.2024.176675_bib28","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.1073\/pnas.210384297","article-title":"Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain","volume":"97","author":"McHugh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2024.176675_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yjmcc.2017.04.005","article-title":"\u03b2-Adrenergic induced SR Ca(2+) leak is mediated by an Epac-NOS pathway","volume":"108","author":"Pereira","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib30","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jacc.2019.07.056","article-title":"Cardiovascular toxicities associated with ibrutinib","volume":"74","author":"Salem","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.RES.0000124606.14903.6F","article-title":"Understanding cardiac alternans: the answer lies in the Ca2+ store","volume":"94","author":"Sipido","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2024.176675_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2011.11.003","article-title":"Role of ranolazine in angina, heart failure, arrhythmias, and diabetes","volume":"133","author":"Sossalla","year":"2012","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2024.176675_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells11081338","article-title":"Ibrutinib in the treatment of solid tumors: current state of knowledge and future directions","volume":"11","author":"Szklener","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.176675_bib34","doi-asserted-by":"crossref","first-page":"H1456","DOI":"10.1152\/ajpheart.00777.2020","article-title":"SK channel blockade prevents hypoxia-induced ventricular arrhythmias through inhibition of Ca(2+)\/voltage uncoupling in hypertrophied hearts","volume":"320","author":"Takahashi","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jacep.2016.07.004","article-title":"Ibrutinib, an approved tyrosine kinase inhibitor as a potential cause of recurrent polymorphic ventricular tachycardia","volume":"2","author":"Tomcs\u00e1nyi","year":"2016","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib36","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2015.04.080","article-title":"Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia","volume":"189","author":"Tsai","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cjca.2017.12.001","article-title":"Increased susceptibility for atrial and ventricular cardiac arrhythmias in mice treated with a single high dose of ibrutinib","volume":"34","author":"Tuomi","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2024.176675_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cvr\/cvm009","article-title":"The sarcoplasmic reticulum and arrhythmogenic calcium release","volume":"77","author":"Venetucci","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2024.176675_bib39","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.bpj.2019.09.041","article-title":"Investigation of the role of myocyte orientations in cardiac arrhythmia using image-based models","volume":"117","author":"Whittaker","year":"2019","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2024.176675_bib40","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-016-0313-y","article-title":"Second-generation inhibitors of Bruton tyrosine kinase","volume":"9","author":"Wu","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2024.176675_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/circ.132.suppl_3.14587","article-title":"Proarrhythmic effects of ibrutinib, a clinically approved inhibitor of Bruton's tyrosine kinase (BTK) used in cancer therapy","volume":"132","author":"Yang","year":"2015","journal-title":"Circulation"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924003637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924003637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T18:57:22Z","timestamp":1719687442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924003637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"alternative-id":["S0014299924003637"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176675","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibrutinib, a Bruton's tyrosine kinase inhibitor, regulates ventricular electromechanical activities and enhances arrhythmogenesis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"176675"}}